4856
Y. Loidreau, T. Besson / Tetrahedron 67 (2011) 4852e4857
(C-3),121.6 (C-4),119.0 (C-6), 118.6 (CN),105.8 (C-2), 34.0 (N(CH3)2);
HRMS calcd for C10H11N3 [MþH]þ 174.1031 found 174.1040.
36.66 mmol), 3a was obtained following Method A after an irra-
diation at 200 ꢀC during 60 min as a dark solid (117 mg; 67%); mp
336 ꢀC; IR (neat) nmax(cmꢂ1): 3084, 1952, 1681, 1618, 1587, 1510,
1482,1341,1320,1284,1260,1199,1094, 927, 904, 847, 806, 749, 742,
4.2.4. (E)-N0-(2-Cyanophenyl)-N,N-dimethylacetimidamide
(5b)
(lit.14). Starting from anthranilonitrile 4 (2.0 g; 16.9 mmol) and N,N-
dimethylacetamide dimethylacetal (6.2 mL; 42.3 mmol), 5b was
obtained after an irradiation at 115 ꢀC during 2 min as white nee-
dles (2.41 g; 78%); mp 68 ꢀC; IR (neat) nmax(cmꢂ1): 2931, 2214, 1575,
1550, 1442, 1413, 1395, 1363, 1314, 1290, 1218, 1191, 1168, 1022, 959,
636; 1H NMR (300 MHz, DMSO-d6):
d
9.33 (d, 1H, J¼2 Hz, H-7), 8.58
(br s, 1H, NH), 8.53 (s, 1H, H-2), 8.48 (dd, 1H, J1¼2 Hz, J2¼9 Hz, H-5),
8.25 (br s, 1H, NH), 7.81 (d, 1H, J¼9 Hz, H-8); 13C NMR (75 MHz,
DMSO-d6): d 162.8 (C-4), 158.6 (C-8a), 153.2 (C-6), 143.8 (C-2), 129.0
(C-7), 126.5 (C-8), 121.4 (C-5), 113.3 (C-4a); HRMS calcd for
875, 839, 182, 755, 722; 1H NMR (300 MHz, DMSO-d6):
d
7.61 (dd,
C8H7N4O2 [MþH]þ 191.0569 found 191.0564.
1H, J1¼1 Hz, J2¼7 Hz, H-3), 7.49 (td, 1H, J1¼1 Hz, J2¼8 Hz, H-5), 7.01
(td, 1H, J1¼1 Hz, J2¼7 Hz, H-4), 6.78 (dd, 1H, J1¼1 Hz, J2¼8 Hz, H-6),
3.02 (br s, 6H, N(CH3)2), 1.89 (s, 3H, CH3); 13C NMR (75 MHz, DMSO-
4.3.2. 2-Methyl-6-nitroquinazolin-4-(3H)-imine (3b). Starting from
acetimidamide derivative 2b (0.29 g; 1.25 mmol) and formamide
(2.0 mL; 50.17 mmol), 3b was converted (8%) following Method B
after an irradiation at 200 ꢀC during 60 min but could not be
isolated.
d6):
d 157.9 (C-7), 155.4 (C-1), 133.5 (C-5), 132.7 (C-3), 123.0 (C-4),
121.0 (C-6), 118.4 (CN), 105.0 (C-2), 37.6 (N(CH3)2), 14.9 (C-8); HRMS
calcd for C11H14N3 [MþH]þ 187.1179 found 187.1178.
4.2.5. (E)-N0-(2-Cyano-4,5-dimethoxyphenyl)-N,N-dimethylformimi-
damide (8a). Starting from 4,5-dimethoxybenzonitrile 7 (4.0 g;
22.5 mmol) and N,N-dimethylformamide dimethylacetal (7.5 mL;
56.12 mmol), 8a was obtained after an irradiation at 90 ꢀC during
10 min as a pale yellow solid (3.98 g; 77%); mp 120 ꢀC; IR (neat)
nmax(cmꢂ1): 3011, 2916, 2813, 2215, 1623, 1602, 1560, 1495, 1419,
1378, 1248, 1213, 1198, 1121, 1099, 1033, 998, 888, 855, 830; 1H NMR
4.3.3. Quinazolin-4-amine (6a). Starting from formimidamide de-
rivative 5a (0.22 g; 1.25 mmol) and formamide (2.0 mL;
50.17 mmol), 6a was obtained following Method B after an irradi-
ation at 200 ꢀC during 10 min as a yellow solid (140 mg; 77%); mp
274 ꢀC; IR (neat) nmax(cmꢂ1): 3076, 2718, 1948, 1684, 1614, 1580,
1559, 1514, 1483, 1457, 1364, 1321, 1290, 1203, 1117, 1023, 921, 757,
736, 629; 1H NMR (300 MHz, DMSO-d6):
d 8.38 (s, 1H, H-2), 8.20 (d,
(300 MHz, DMSO-d6):
1H, H-6), 3.82 (s, 3H, OCH3), 3.72 (s, 3H, OCH3) 3.05 (s, 3H, NCH3),
2.96 (s, 3H, NCH3); 13C NMR (75 MHz, DMSO-d6):
154.5 (C-5),
d
7.92 (s, 1H, NCHN), 7.09 (s, 1H, H-3), 6.74 (s,
1H, J¼8 Hz, H-8), 7.77 (m, 3H, J1¼1 Hz, J2¼8 Hz, H-5 and NH2), 7.66
(d, 1H, J¼8 Hz, H-7), 7.48 (td, 1H, J1¼1 Hz, J2¼8 Hz, H-6); 13C NMR
d
(75 MHz, DMSO-d6): d 161.7 (C-4), 155.4 (C-2), 149.6 (C-8a), 132.7
153.3 (C-7), 150.6 (C-4), 143.9 (C-1), 119.1 (CN), 114.1 (C-3), 102.6 (C-
6), 95.8 (C-2), 55.9 (OCH3), 55.6 (OCH3), 33.9 (N(CH3)2); HRMS calcd
for C12H16N3O2 [MþH]þ 234.1243 found 234.1243.
(C-7), 127.3 (C-8), 125.3 (C-5), 123.5 (C-6), 114.3 (C-4a); HRMS calcd
for C8H8N3 [MþH]þ 146.0718 found 146.0714.
4.3.4. 2-Methylquinazolin-4-amine (6b) (lit.15b). Starting from ace-
timidamide derivative 5b (0.235 g; 1.25 mmol), formamide (2.0 mL;
50.17 mmol) and InCl3 (0.277 g; 1.25 mmol), 6b was obtained fol-
lowing Method B after an irradiation at 150 ꢀC during 35 min as
a pale yellow solid (0.187 g; 94%); mp 306 ꢀC; IR (neat) nmax(cmꢂ1):
2886, 1560, 1508, 1466, 1396, 1369, 1324, 1128, 1056, 986, 875, 744,
4.2.6. (E)-N0-(2-Cyano-4,5-dimethoxyphenyl)-N,N-dimethylacetimi-
damide (8b). Starting from 4,5-dimethoxybenzonitrile 7 (1.0 g;
5.6 mmol) and N,N-dimethylacetamide dimethylacetal (2.1 mL;
14.0 mmol), 8b was obtained after an irradiation at 80 ꢀC during
6 min. The crude product was previously purified directly by col-
umn chromatography and gave 8b (1.31 g; 95%) as an orange oil; IR
(neat) nmax(cmꢂ1): 2935, 2210, 1593, 1494, 1440, 1416, 1381, 1365,
1251, 1214, 1189, 1174, 1113, 1020, 1003, 948, 843, 765, 754; 1H NMR
640; 1H NMR (300 MHz, DMSO-d6):
d
8.17 (d, 1H, J¼8 Hz, H-8), 7.72
(m, 3H, J1¼1 Hz, J2¼8 Hz, H-5 and NH2), 7.67 (d, 1H, J¼8 Hz, H-7),
7.39 (td, 1H, J1¼1 Hz, J2¼8 Hz, H-6); 13C NMR (75 MHz, DMSO-d6):
(300 MHz, DMSO-d6):
3H, OCH3), 3.73 (s, 3H, OCH3) 3.00 (br s, 6H, N(CH3)2), 1.87 (s, 3H,
CH3); 13C NMR (75 MHz, DMSO-d6):
158.1 (C-7), 153.1 (C-5), 151.4
d
7.10 (s, 1H, H-3), 6.36 (s, 1H, H-6), 3.77 (s,
d 163.6 (C-4), 162.9 (C-2), 150.1 (C-8a), 132.6 (C-7), 126.7 (C-8), 124.4
(C-5), 123.4 (C-6), 112.5 (C-4a), 25.8 (CH3); HRMS calcd for C9H10N3
d
[MþH]þ 160.0875 found 160.0863.
(C-4), 143.4 (C-1), 118.8 (CN), 113.8 (C-3), 106.5 (C-6), 94.6 (C-2),
55.9 (OCH3), 55.6 (OCH3), 37.5 (N(CH3)2), 15.0 (C-8); HRMS calcd for
C13H18N3O2 [MþH]þ 248.1399 found 248.1393.
4.3.5. 6,7-Dimethoxyquinazolin-4-amine (9a). Starting from 4,5-
dimethoxybenzonitrile 7 (0.227 g; 1.25 mmol) and formamide
(2.0 mL; 50.17 mmol), 9a was obtained following Method A after an
irradiation at 200 ꢀC during 60 min as a pale yellow solid (0.146 g;
57%); mp 202 ꢀC; IR (neat) nmax(cmꢂ1): 3335, 3082,1676,1585,1476,
1452, 1438, 1337, 1283, 1248, 1220, 1196, 1165, 1115, 1029, 990, 847,
4.3. General procedures for the syntheses of quinazolin4-
amines
All quinazolines could be obtained by two methods. Each de-
rivative was described once using the best method.
835, 785, 721, 667, 630; 1H NMR (300 MHz, DMSO-d6):
H-2), 7.56 (s, 1H, H-8), 7.40 (br s, 2H, NH2), 7.05 (s, 1H, H-5), 3.89 (s,
3H, OCH3), 3.86 (s, 3H, OCH3); 13C NMR (75 MHz, DMSO-d6):
160.4
d 8.25 (s, 1H,
Method A: Benzonitriles were suspended in formamide
(40 equiv) and InCl3 (1 equiv), or not, in a sealed vial and were ir-
radiated at 400 W under microwaves. The residue was cooled to
room temperature, filtrated, washed with water and dried.
Method B: Formimidamide or acetimidamide intermediates
were suspended in formamide (40 equiv) and InCl3 (1 equiv), or
not, in a sealed vial and were irradiated at 400 W under micro-
waves. The residue was cooled to room temperature, filtrated,
washed with water and dried.
d
(C-4), 153.9 (C-7), 153.8 (C-2), 148.1 (C-6), 146.8 (C-8a), 107.9 (C-4a),
106.7 (C-8), 102.6 (C-5), 55.9 (OCH3), 55.6 (OCH3); HRMS calcd for
C10H12N3O2 [MþH]þ 206.0930 found 206.0928.
4.3.6. 2-Methyl-6,7-dimethoxyquinazolin-4-amine
(9b). Starting
from acetimidamide 8b (0.31 g; 1.25 mmol), formamide (2.0 mL;
50.17 mmol) and InCl3 (0.277 mg; 1.25 mmol), 9b was obtained
following Method B after an irradiation at 150 ꢀC during 40 min as
a yellow solid (0.186 g; 68%); mp >350 ꢀC; IR (neat) nmax(cmꢂ1):
3117, 2163, 1683, 1574, 1500, 1438, 1386, 1289, 1215, 1099, 774; 1H
In the two methods, purification by column chromatography
over silica gel using a gradient of CH2Cl2/EtOAc (from 100/0 to 0/
100, v/v) as the eluent gave the desired compounds.
NMR (300 MHz, DMSO-d6):
7.00 (s, 1H, H-5), 3.86 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 2.36 (s, 3H,
CH3); 13C NMR (75 MHz, DMSO-d6):
161.7 (C-4), 160.5 (C-7), 153.9
(C-2), 147.5 (C-6), 147.1 (C-8a), 106.5 (C-4a), 105.9 (C-8), 102.6 (C-5),
d 7.52 (s, 1H, H-8), 7.30 (br s, 2H, NH2),
4.3.1. 6-Nitroquinazolin-4-(3H)-imine (3a). Starting from 2-amino-
5-nitrobenzonitrile 1 (0.2 g; 0.92 mmol) and formamide (1.46 mL;
d